Cspc Pharmaceutical Group
(OTC) CSPCY
Cspc Pharmaceutical Group Financials at a Glance
Market Cap
$13.45B
Revenue (TTM)
$46.61B
Net Income (TTM)
$6.41B
EPS (TTM)
$0.19
P/E Ratio
24.85
Dividend
$0.12
Beta (Volatility)
0.47 (Low)
Dividend
$0.12
Beta (Volatility)
0.47 (Low)
Price
$4.62
Volume
4,694
Open
$4.57
Price
$4.62
Volume
4,694
Open
$4.57
Previous Close
$4.67
Daily Range
$4.56 - $4.68
52-Week Range
$2.73 - $5.83
Dividend
$0.12
Beta (Volatility)
0.47 (Low)
Price
$4.62
Volume
4,694
Open
$4.57
Previous Close
$4.67
Daily Range
$4.56 - $4.68
52-Week Range
$2.73 - $5.83
CSPCY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cspc Pharmaceutical Group
Industry
Pharmaceuticals
Sector
Health CareEmployees
19,700
CEO
Lei Cai, PhD
Website
www.cspc.com.hkHeadquarters
Shijiazhuang, 050035, CN
CSPCY Financials
Key Financial Metrics (TTM)
Gross Margin
66%
Operating Margin
15%
Net Income Margin
15%
Return on Equity
12%
Return on Capital
11%
Return on Assets
8%
Earnings Yield
4.02%
Dividend Yield
0.03%
Payout Ratio
44.03%
Stock Overview
Market Cap
$13.45B
Shares Outstanding
2.88B
Volume
4.69K
Short Interest
0.00%
Avg. Volume
3.99K
Financials (TTM)
Gross Profit
$18.47B
Operating Income
$4.30B
EBITDA
$5.83B
Operating Cash Flow
$4.53B
Capital Expenditure
$2.68B
Free Cash Flow
$1.86B
Cash & ST Invst.
$9.87B
Total Debt
$714.01M
Cspc Pharmaceutical Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$13.91B
+83.4%
Gross Profit
$9.12B
-51.2%
Gross Margin
65.57%
N/A
Market Cap
$13.45B
N/A
Market Cap/Employee
$628.63K
N/A
Employees
21,400
N/A
Net Income
$1.46B
+5.7%
EBITDA
$2.32B
+29.6%
Quarterly Fundamentals
Net Cash
$9.16B
-26.0%
Accounts Receivable
$10.63B
+5.0%
Inventory
$3.44B
-0.3%
Long Term Debt
$201.24M
+88.0%
Short Term Debt
$512.77M
-14.5%
Return on Assets
8.07%
N/A
Return on Invested Capital
10.56%
N/A
Free Cash Flow
$289.99M
-33.8%
Operating Cash Flow
$455.84M
-69.8%